King's College London

Research portal

Regulatory T cells: tolerance induction in solid organ transplantation

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)197-210
JournalClinical and Experimental Immunology
Issue number2
Early online date25 May 2017
Accepted/In press31 Mar 2017
E-pub ahead of print25 May 2017
PublishedAug 2017

King's Authors


The concept of regulatory T cell (Treg ) therapy in transplantation is now a reality. Significant advances in science and technology have enabled us to isolate human Tregs , expand them to clinically relevant numbers and infuse them into human transplant recipients. With several Phase I/II trials under way investigating Treg safety and efficacy it is now more crucial than ever to understand their complex biology. However, our journey is by no means complete; results from these trials will undoubtedly provoke both further knowledge and enquiry which, alongside evolving science, will continue to drive the optimization of Treg therapy in the pursuit of transplantation tolerance. In this review we will summarize current knowledge of Treg biology, explore novel technologies in the setting of Treg immunotherapy and address key prerequisites surrounding the clinical application of Tregs in transplantation.

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454